NLRP3 and metabolic dysfunction-associated steatotic liver disease: This reduction in oxidative stress inhibited NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) inflammasome activation and slowed hepatic steatosis progression in NAFLD patients (75).